Trademark: 88250571
Word
LIQUID BIOPSY IS REVOLUTIONIZING CANCER TREATMENT. NRICHDX EMPOWERS THAT REVOLUTION.
Status Date
Tuesday, November 3, 2020
Registration Number
6190469
Registration Date
Tuesday, November 3, 2020
Filing Date
Friday, January 4, 2019
Published for Opposition
Tuesday, May 7, 2019
10 cell culture and cancer diagnostics tests, namely, liquid biopsy testing systems consisting of a specimen chamber assembly and magnetic materials used to sequester target analytes of interest within a liquid sample for isolation and characterization
Nov 3, 2020
Registered-Principal Register
Oct 2, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 1, 2020
Allowed Principal Register - Sou Accepted
Sep 18, 2020
Statement Of Use Processing Complete
Sep 2, 2020
Use Amendment Filed
Sep 18, 2020
Case Assigned To Intent To Use Paralegal
Sep 2, 2020
Teas Statement Of Use Received
Jul 4, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 2, 2020
Extension 2 Granted
Jul 2, 2020
Extension 2 Filed
Jul 2, 2020
Teas Extension Received
Dec 31, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 27, 2019
Extension 1 Granted
Dec 27, 2019
Extension 1 Filed
Dec 27, 2019
Teas Extension Received
Jul 2, 2019
Noa E-Mailed - Sou Required From Applicant
May 7, 2019
Official Gazette Publication Confirmation E-Mailed
May 7, 2019
Published For Opposition
Apr 17, 2019
Notification Of Notice Of Publication E-Mailed
Mar 22, 2019
Approved For Pub - Principal Register
Mar 21, 2019
Assigned To Examiner
Jan 26, 2019
New Application Office Supplied Data Entered In Tram
Jan 8, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
